Top

World Journal of Urology

Published in:

01-09-2021 | Kidney Transplantation | Topic Paper

Scoping review: hotspots for COVID-19 urological research: what is being published and from where?

Authors: Liang G. Qu, Marlon Perera, Nathan Lawrentschuk, Rainy Umbas, Laurence Klotz

Published in: World Journal of Urology | Issue 9/2021

Abstract

Purpose

Contemporary, original research should be utilised to inform guidelines in urology relating to the COVID-19 pandemic. This comprehensive review aimed to: identify all up-to-date original publications relating to urology and COVID-19, characterise where publications were from, and outline what topics were investigated.

Methods

This review utilised a search strategy that assessed five electronic databases, additional grey literature, and global trial registries. All current published, in-press, and pre-print manuscripts were included. Eligible studies were required to be original research articles of any study design, reporting on COVID-19 or urology, in any of study population, intervention, comparison, or outcomes. Included studies were reported in a narrative synthesis format. Data were summarised according to primary reported outcome topic. A world heatmap was generated to represent where included studies originated from.

Results

Of the 6617 search results, 48 studies met final inclusion criteria, including 8 pre-prints and 7 ongoing studies from online registries. These studies originated from ten countries according to first author affiliation. Most studies originated from China (n = 13), followed by Italy (n = 12) and USA (n = 11). Topics of the study included pathophysiological, administrative, and clinical fields: translational (n = 14), COVID-19-related outcomes (n = 5), urology training (n = 4), telemedicine (n = 7), equipment and safety (n = 2), urology in general (n = 4), uro-oncology (n = 3), urolithiasis (n = 1), and kidney transplantation (n = 8).

Conclusion

This review has outlined available original research relevant to COVID-19 and urology from the international community. This summary may serve as a guide for future research priorities in this area.

Available only for authorised users

Carenzo L, Costantini E, Greco M, Barra F, Rendiniello V, Mainetti M, Bui R, Zanella A, Grasselli G, Lagioia M (2020) Hospital surge capacity in a tertiary emergency referral centre during the COVID-19 outbreak in Italy. Anaesthesia 75:928–934CrossRef

Wang H, Wu J, Wei Y, Zhu Y, Ye D (2020) Surgical volume, safety, drug administration, and clinical trials during COVID-19: single-center experience in Shanghai, China. Eur Urol 78:120–122CrossRef

Van Bruwaene S (2020) Surgical safety. World J Urol 38(6):1349–1350. https://doi.org/10.1007/s00345-020-03249-1CrossRefPubMed

Engel D, Furrer MA, Wuethrich PY, Loffel LM (2020) Surgical safety in radical cystectomy: the anesthetist’s point of view-how to make a safe procedure safer. World J Urol 38(6):1359–1368. https://doi.org/10.1007/s00345-019-02839-yCrossRefPubMed

Pang KH, Carrion DM, Rivas JG, Mantica G, Mattigk A, Pradere B, Esperto F, Urology ESoRi (2020) The impact of COVID-19 on European health care and urology trainees. Eur Urol 78:6–8CrossRef

Spinoit A-F, Haid B, Hiess M, Banuelos B, Lt H, Radford A, Silay MS (2020) Impact of the COVID-19 pandemic on paediatric urology practice in Europe: a reflection from the European association of urology young academic urologists. Eur Urol 78:122–124CrossRef

Wallis CJ, Novara G, Marandino L, Bex A, Kamat AM, Karnes RJ, Morgan TM, Mottet N, Gillessen S, Bossi A (2020) Risks from deferring treatment for genitourinary cancers: a collaborative review to aid triage and management during the COVID-19 pandemic. Eur Urol 78:29–42CrossRef

Ribal MJ, Cornford P, Briganti A, Knoll T, Gravas S, Babjuk M, Harding C, Breda A, Bex A, Rassweiler JJ (2020) European Association of Urology Guidelines Office Rapid Reaction Group: an organisation-wide collaborative effort to adapt the European association of urology guidelines recommendations to the coronavirus disease 2019 Era. Eur Urol 78:21–28CrossRef

Desouky E (2020) Impact of COVID-19 on urologists: learning on the go. Eur Urol Focus 6:1132–1134. https://doi.org/10.1016/j.euf.2020.04.008CrossRefPubMedPubMedCentral

10.

Chan MC, Yeo SEK, Chong YL, Lee YM (2020) Stepping forward: urologists’ efforts during the COVID-19 outbreak in Singapore. Eur Urol. https://doi.org/10.1016/j.eururo.2020.03.004CrossRefPubMedPubMedCentral

11.

Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MD, Horsley T, Weeks L (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169(7):467–473CrossRef

12.

Aro T, Koo K, Matlaga BR (2020) Infrequent use of clinical trials registries in published systematic reviews in urology. World J Urol 38(5):1335–1340. https://doi.org/10.1007/s00345-019-02914-4CrossRefPubMed

13.

World Health Organization (2020) Coronavirus disease 2019 (COVID-19): situation report. 118

14.

CASP U (2017) Critical appraisal skills programme (CASP). Qual Res Checkl 31(13):449

15.

Farkash EA, Wilson AM, Jentzen JM (2020) Ultrastructural evidence for direct renal infection with SARS-CoV-2. J Am Soc Nephrol JASN 31:1683–1687. https://doi.org/10.1681/ASN.2020040432CrossRefPubMed

16.

Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, Huang Z, Li X, Deng K, Lin B, Gao Z (2020) SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. J Med Virol. https://doi.org/10.1002/jmv.25936CrossRefPubMedPubMedCentral

17.

Pan F, Xiao X, Guo J, Song Y, Li H, Patel DP, Spivak AM, Joseph PA, Zhang X, Xiong C (2020) No evidence of SARS-CoV-2 in semen of males recovering from COVID-19. Fertil Steril 113:1135–1139CrossRef

18.

Song C, Wang Y, Li W, Hu B, Chen G, Xia P, Wang W, Li C, Diao F, Hu Z (2020) Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients. Biol Reprod 103:4–6CrossRef

19.

Quan W, Chen J, Liu Z, Tian J, Chen X, Wu T, Ji Z, Tang J, Chu H, Xu H (2020) No SARS-CoV-2 in expressed prostatic secretion of patients with coronavirus disease 2019: a descriptive multicentre study in China

20.

Chai P, Yu J, Ge S, Jia R, Fan X (2020) Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis. J Hematol Oncol 13(1):43. https://doi.org/10.1186/s13045-020-00883-5CrossRefPubMedPubMedCentral

21.

Yang J, Li H, Hu S, Zhou Y (2020) ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19. Aging 12(8):6518–6535. https://doi.org/10.18632/aging.103100CrossRefPubMedPubMedCentral

22.

Song H, Seddighzadeh B, Cooperberg MR, Huang FW (2020) Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells. Eur Urol

23.

Wang Z, Xu X (2020) scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, Leydig and Sertoli cells. Cells 9(4):920CrossRef

24.

Shen Q, Xiao X, Aierken A, Liao M, Hua J (2020) The ACE2 expression in Sertoli cells and Germ cells may cause male reproductive disorder after SARS-CoV-2 Infection. J Cel Mol Med 24:9472–9477CrossRef

25.

Ren X, Wei X, Li G, Ren S, Chen X, Zhang T, Zhang X, Lu Z, You Z, Wang S (2020) Multiple expression assessments of ACE2 and TMPRSS2 SARS-CoV-2 entry molecules in the urinary tract and their associations with clinical manifestations of COVID-19. bioRxiv

26.

Wu S, Miao L, Zhou Q, Gao C, Liu J, Zhan Q, Guo B, Li F, Wang Y, Xu H (2020) Suppression of androgen receptor (AR)-ACE2/TMPRSS2 axis by AR antagonists may be therapeutically beneficial for male COVID patients. SSRN

27.

Ma L, Xie W, Li D, Shi L, Mao Y, Xiong Y, Zhang Y, Zhang M (2020) Effect of SARS-CoV-2 infection upon male gonadal function: a single center-based study. medRxiv

28.

Schroeder M, Tuku B, Jarczak D, Nierhaus A, Bai T, Jacobsen H, Zickler M, Mueller Z, Stanelle-Bertram S, Meinhardt A (2020) The majority of male patients with COVID-19 present low testosterone levels on admission to Intensive Care in Hamburg, Germany: a retrospective cohort study. medRxiv

29.

Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV, Carbone GM, Cavalli A, Pagano F, Ragazzi E, Prayer-Galetti T, Alimonti A (2020) Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n = 4532). Ann Oncol Off J Eur Soc Med Oncol 31:1040–1045. https://doi.org/10.1016/j.annonc.2020.04.479CrossRef

30.

Duga S, Asselta R, Lazzeri M, Guazzoni G, Azzolini E, Buffi N, Fasulo V, Persico F, Saita A, Hurle R (2020) Impact of anti-androgenic therapies on COVID-19: an observational study in male population from a COVID-19 regional centre of Lombardy (Italy). medRxiv

31.

Antonio Maria G, Vasileios P, Giacomo Piero I, Ai Ling Loredana R, Marco R, Giulia G, Stefania R, Federica M, Gregori A (2020) Urologic surgery and invasive procedures during coronavirus pandemic: retrospective comparison of risk infection in a referral Covid hospital and in a free-Covid hospital. Urologia 391560320927106. https://doi.org/10.1177/0391560320927106

32.

Abdessater M, Roupret M, Misrai V, Matillon X, Gondran-Tellier B, Freton L, Vallee M, Dominique I, Felber M, Khene ZE, Fortier E, Lannes F, Michiels C, Grevez T, Szabla N, Boustany J, Bardet F, Kaulanjan K, Seizilles de Mazancourt E, Ploussard G, Pinar U, Pradere B (2020) COVID19 pandemic impacts on anxiety of French urologist in training: outcomes from a national survey. Prog Urol J Assoc Fr Urol Soc Fr Urol 30:448–455. https://doi.org/10.1016/j.purol.2020.04.015CrossRef

33.

Amparore D, Claps F, Cacciamani GE, Esperto F, Fiori C, Liguori G, Serni S, Trombetta C, Carini M, Porpiglia F, Checcucci E, Campi R (2020) Impact of the COVID-19 pandemic on urology residency training in Italy. Minerva Urol Nefrol Ital J Urol Nephrol 72:505–509. https://doi.org/10.23736/S0393-2249.20.03868-0CrossRef

34.

Luciani LG, Mattevi D, Cai T, Giusti G, Proietti S, Malossini G (2020) Teleurology in the time of Covid-19 pandemic: here to Stay? Urology. https://doi.org/10.1016/j.urology.2020.04.004CrossRefPubMed

35.

Lonergan PE, Washington SL, Branagan L, Gleason N, Pruthi RS, Carroll PR, Odisho AY (2020) Rapid utilization of telehealth in a comprehensive cancer center as a response to COVID-19. medRxiv

36.

Boehm K, Ziewers S, Brandt MP, Sparwasser P, Haack M, Willems F, Thomas A, Dotzauer R, Hofner T, Tsaur I, Haferkamp A, Borgmann H (2020) Telemedicine online visits in urology during the COVID-19 pandemic-potential, risk factors, and patients’ perspective. Eur Urol. https://doi.org/10.1016/j.eururo.2020.04.055CrossRefPubMedPubMedCentral

37.

Davis C, Novak M, Patel A, Davis C, Fitzwater R, Hale N (2020) The COVID-19 catalyst: analysis of a tertiary academic institution’s rapid assimilation of telemedicine. Urol Pract. https://doi.org/10.1097/UPJ.0000000000000155CrossRefPubMedCentral

38.

Borchert A, Baumgarten L, Dalela D, Jamil M, Budzyn J, Kovacevic N, Yaguchi G, Palma-Zamora I, Perkins S, Bazzi M, Wong P, Sood A, Peabody J, Rogers CG, Dabaja A, Atiemo H (2020) Managing urology consultations during COVID-19 pandemic: application of a structured care pathway. Urology. https://doi.org/10.1016/j.urology.2020.04.059CrossRefPubMed

39.

Lobo JM, Horton B, Jones RA, Tyson T, Hill-Collins P, Sims T, Rueb JJ, Corey T, Rheuban K, Battle P (2020) Blinded comparison of clarity, proficiency and diagnostic capability of tele-cystoscopy compared to traditional cystoscopy, a pilot study. J Urol. https://doi.org/10.1097/JU.0000000000001092CrossRefPubMed

40.

Sobel D, Gn M, O'Rourke TK, Tucci C, Pareek G, Golijanin D, Elsamra S (2020) Personal protective equipment for common urologic procedures before and during the United States COVID-19 pandemic: a single institution study. Urology 141:1–6. https://doi.org/10.1016/j.urology.2020.04.083CrossRefPubMed

41.

Souders CP, Zhao H, Ackerman AL (2020) Considerations for bedside urologic procedures in patients with severe acute respiratory syndrome coronavirus-2. Urology 142:26–28. https://doi.org/10.1016/j.urology.2020.04.066CrossRefPubMed

42.

Madanelo M, Ferreira C, Rocha M, Nunes-Carneiro D, Correia J, Teixeira B, Mendes G, Tavares C, Pinto A, Mesquita S (2020) El impacto de la pandemia del COVID-19 en la utilización de los servicios urológicos de urgencias. Acta Urol Esp

43.

Mantica G, Suardi N, Terrone C (2020) Re: Ming-Chun Chan, Sharon EK Yeo, Yew-Lam Chong, Yee-Mun Lee (2020) Stepping forward: urologists’ Efforts During the COVID-19 Outbreak in Singapore Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2020.03.004. Eur Urol 78:e42CrossRef

44.

Campi R, Amparore D, Capitanio U, Checcucci E, Salonia A, Fiori C, Minervini A, Briganti A, Carini M, Montorsi F, Serni S, Porpiglia F (2020) Assessing the burden of nondeferrable major uro-oncologic surgery to guide prioritisation strategies during the COVID-19 pandemic: insights from three Italian high-volume referral centres. Eur Urol. https://doi.org/10.1016/j.eururo.2020.03.054CrossRefPubMedPubMedCentral

45.

Ficarra V, Mucciardi G, Giannarini G (2020) Re: Riccardo Campi, Daniele Amparore, Umberto Capitanio, et al. Assessing the burden of urgent major uro-oncologic surgery to guide prioritisation strategies during the COVID-19 pandemic: insights from three Italian high-volume referral centres. Eur Urol 78:e16–e17. https://doi.org/10.1016/j.eururo.2020.04.037CrossRefPubMedPubMedCentral

46.

Marandino L, Di Maio M, Procopio G, Cinieri S, Beretta GD, Necchi A (2020) The shifting landscape of genitourinary oncology during the COVID-19 pandemic and how Italian oncologists reacted: results from a national survey. Eur Urol 78:e27–e35CrossRef

47.

Tefik T, Guven S, Villa L, Gokce MI, Kallidonis P, Petkova K, Kiremit MC, Sonmez MG, de Lorenzis E, Eryildirim B (2020) Urolithiasis practice patterns following the COVID-19 pandemic: overview from the EULIS collaborative research working group. Eur Urol 78:e21–e24CrossRef

48.

Montagud-Marrahi E, Cofan F, Torregrosa JV, Cucchiari D, Ventura-Aguiar P, Revuelta I, Bodro M, Pineiro GJ, Esforzado N, Ugalde J, Guillen E, Rodriguez-Espinosa D, Campistol JM, Oppenheimer F, Moreno A, Diekmann F (2020) Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single centre cohort of kidney recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. https://doi.org/10.1111/ajt.15970CrossRef

49.

Nair V, Jandovitz N, Hirsch JS, Nair G, Abate M, Bhaskaran M, Grodstein E, Berlinrut I, Hirschwerk D, Cohen SL, Davidson KW, Dominello AJ, Osorio GA, Richardson S, Teperman LW, Molmenti EP (2020) COVID-19 in kidney transplant recipients. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg 20:1819–1825. https://doi.org/10.1111/ajt.15967CrossRef

50.

The Columbia University Kidney Transplant Program (2020) Early description of coronavirus 2019 disease in kidney transplant recipients in New York. J Am Soc Nephrol JASN 31:1150–1156. https://doi.org/10.1681/ASN.2020030375CrossRef

51.

Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, Maffei C, Possenti S, Zambetti N, Moscato M, Venturini M, Affatato S, Gaggiotti M, Bossini N, Scolari F (2020) A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int. https://doi.org/10.1016/j.kint.2020.04.002CrossRefPubMedPubMedCentral

52.

Abrishami A, Samavat S, Behnam B, Arab-Ahmadi M, Nafar M, Taheri MS (2020) Clinical course, imaging features, and outcomes of COVID-19 in kidney transplant recipients. Eur Urol 78:281–286CrossRef

53.

Zhang H, Chen Y, Yuan Q, Xia Q-X, Zeng X-P, Peng J-T, Liu J, Xiao X-Y, Jiang G-S, Xiao H-Y (2020) Identification of kidney transplant recipients with coronavirus disease 2019. Eur Urol 77:742–747CrossRef

54.

Zhu L, Gong N, Liu B, Lu X, Chen D, Chen S, Shu H, Ma K, Xu X, Guo Z (2020) Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in wuhan, China. Eur Urol 77:748–754CrossRef

55.

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271–280CrossRef

56.

Carrion DM, Rodriguez-Socarras ME, Mantica G, Esperto F, Cebulla A, Duijvesz D, Patruno G, Vasquez JL, Veneziano D, Diez-Sebastian J, Gozen AS, Palou J, Gomez Rivas J (2020) Current status of urology surgical training in Europe: an ESRU-ESU-ESUT collaborative study. World J Urol 38(1):239–246. https://doi.org/10.1007/s00345-019-02763-1CrossRefPubMed

57.

Cini C, Bortot G, Sforza S, Mantovani A, Landi L, Esposito C, Escolino M, Masieri L (2020) Paediatric urology practice during COVID-19 pandemic. J Pediatr Urol. https://doi.org/10.1016/j.jpurol.2020.04.023CrossRefPubMedPubMedCentral

58.

Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W (2020) Detection of SARS-CoV-2 in different types of clinical specimens. JAMA 323(18):1843–1844PubMedPubMedCentral

59.

Lescure F-X, Bouadma L, Nguyen D, Parisey M, Wicky P-H, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q (2020) Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis 20:697–706CrossRef

Title: Scoping review: hotspots for COVID-19 urological research: what is being published and from where?
Authors: Liang G. Qu
Marlon Perera
Nathan Lawrentschuk
Rainy Umbas
Laurence Klotz
Publication date: 01-09-2021
Publisher: Springer Berlin Heidelberg
Keywords: Kidney Transplantation
Kidney Transplantation
Kidney Transplantation
Severe Acute Respiratory Syndrome Coronavirus
COVID-19
Telemedicine
Kidney Transplantation
Kidney Transplantation
Kidney Transplantation
Published in: World Journal of Urology / Issue 9/2021
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-020-03434-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Scoping review: hotspots for COVID-19 urological research: what is being published and from where?

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 9/2021

En-bloc resection of bladder tumour as primary treatment for patients with non-muscle-invasive bladder cancer: routine implementation in a multi-centre setting

Enhanced antibiotic prophylaxis and infection-related complications following prostate biopsy

Microbiological diagnosis in urogenital tuberculosis: the Holy Grail still Eludes

Comment on: Shatagopam K, Bahler CD, Sundaram CP. Renorrhaphy techniques and effect on renal function with robotic partial nephrectomy. World J Urol. 2020;38: 1109–12

Effectiveness of convective water vapor energy therapy versus prostatic urethral lift for symptomatic benign prostatic hyperplasia: a systematic review and indirect comparison

Does post prostatectomy decipher score predict biochemical recurrence and impact care?